The International Education Initiative on Molecular Targeted Therapy of Cancer (MTTC) was initiated in 2001 with the aim of developing content for high quality medical education for oncologists. Based on the presentations of the first International Workshop on MTTC in Paris in 2002, an educational core curriculum has been developed, directed by the members of the International Education Council.

This 9th Latin American Workshop on MTTC is an activity within the International Medical Educational Initiative on MTTC in Latin America, which began with the 1st Latin American Workshop on MTTC in Bariloche, Argentina (2003) and was followed by further workshops in Cancun, Mexico (2004), Trancoso, Brazil (2005), Pucón, Chile (2006), Rio de Janeiro, Brazil (2007), Buenos Aires, Argentina (2008), Quito, Ecuador (2009) and Lima, Peru (2010).

A distinguished group of Latin American oncology experts from different disciplines will be giving educational presentations on the basic mode of action and clinical application of various targeted therapies.

Learning objectives
The objectives of this workshop are:

• To understand the basics of signal transduction, angiogenesis and antibody-based therapy with regard to cancer therapy
• To understand the benefit of targeted therapy of cancer
• To relate the latest developments in the fields of signal transduction, angiogenesis, and antibody-based therapy with regard to targeted cancer therapy

This workshop is designed to foster extensive discussion of the presented data.

Target audience
Oncologists, radiation-oncologists, surgeons, pathologists.

More Information
Find out more about this meeting by using the links in the menu to the right of this page or Download Brochure (PDF)

Accreditation
The 9th Latin American MTTC Workshop (Santiago, Chile - November 4-5, 2011) will be submitted for CME accreditation by European Society for Medical Oncology (ESMO).